The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
94778752 9477875 2 F 20160727 20130827 20160810 EXP US-RANBAXY-2013US-72547 RANBAXY DAVIS JJ, BUCK NS, SWENSON JD, JOHNSON KB, GREIS PE. SEROTONIN SYNDROME MANIFESTING AS PATIENT MOVEMENT DURING TOTAL INTRAVENOUS ANESTHESIA WITH PROPOFOL AND REMIFENTANIL. J CLIN ANESTH. 2013;FEB;25(1):52-4 23.00 YR M Y 0.00000 20160810 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
94778752 9477875 1 PS FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 Unknown 60 MG, DAILY 76990 60 MG
94778752 9477875 2 I FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 76990
94778752 9477875 3 I FENTANYL. FENTANYL 1 Unknown 250 ?G, SINGLE 0 250 UG
94778752 9477875 4 I Remifentanil REMIFENTANIL 1 Unknown 0.2 MCG/KG/MIN Y 0 INFUSION
94778752 9477875 5 I Remifentanil REMIFENTANIL 1 Intravenous bolus 100 MCG Y 0 INFUSION
94778752 9477875 6 SS PROPOFOL. PROPOFOL 1 Unknown 0.1 MG/KG/MIN Y 0 INFUSION
94778752 9477875 7 SS PROPOFOL. PROPOFOL 1 Intravenous bolus 50 MG Y 0 INFUSION
94778752 9477875 8 SS PROPOFOL. PROPOFOL 1 Unknown 150 MG Y 0
94778752 9477875 9 C BUPIVACAINE. BUPIVACAINE 1 Unknown 30 ML U 0
94778752 9477875 10 C DIAZEPAM. DIAZEPAM 1 Unknown 10 MG, QD (AT NIGHT) U 0 10 MG
94778752 9477875 11 C DIAZEPAM. DIAZEPAM 1 U 0
94778752 9477875 12 C EPINEPHRINE. EPINEPHRINE 1 Unknown 5 ?G/ML U 0
94778752 9477875 13 C MIDAZOLAM MIDAZOLAMMIDAZOLAM HYDROCHLORIDE 1 Unknown 2 MG U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
94778752 9477875 1 Depression
94778752 9477875 2 Anxiety
94778752 9477875 3 Induction of anaesthesia
94778752 9477875 4 Induction of anaesthesia
94778752 9477875 6 Induction of anaesthesia
94778752 9477875 8 Induction of anaesthesia
94778752 9477875 9 Product used for unknown indication
94778752 9477875 10 Depression
94778752 9477875 11 Anxiety
94778752 9477875 12 Tissue expansion procedure
94778752 9477875 13 Sedation

Outcome of event

Event ID CASEID OUTC COD
94778752 9477875 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
94778752 9477875 Drug interaction
94778752 9477875 Serotonin syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found